Published in Ann N Y Acad Sci on January 01, 1986
Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol (1990) 1.28
A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet (1998) 3.65
A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A (2001) 2.39
Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol (1998) 2.24
CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet (2000) 2.18
Linkage analysis of neurofibromatosis (von Recklinghausen disease). J Med Genet (1983) 2.13
Unique features of the CAG repeats in Machado-Joseph disease. Nat Genet (1995) 2.06
Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol (1998) 1.93
Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain (1999) 1.84
Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry (2003) 1.56
Effect of heat stress on muscle sympathetic nerve activity in humans. J Auton Nerv Syst (1997) 1.55
Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease. Neurology (2011) 1.54
Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease. Hum Mol Genet (1995) 1.44
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler (2008) 1.44
Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP. Neurology (2009) 1.43
Sensory conduction study of cisplatin neuropathy: preservation of small myelinated fibers. Intern Med (1997) 1.43
Nerve growth factor effects and receptors in cultured human neuroblastoma cell lines. J Neurosci Res (1982) 1.42
Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS. Neurology (2002) 1.41
Selective loss of small myelinated fibers in the lateral corticospinal tract due to midbrain infarction. Neurology (1996) 1.40
Suppressive effects of 4-acetylaminophenylacetic acid (actarit) on experimental autoimmune encephalomyelitis in rats. Immunopharmacology (1998) 1.38
Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem (2000) 1.33
Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry (2011) 1.32
Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology (1997) 1.29
Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology (2004) 1.25
Course and distribution of facial corticobulbar tract fibres in the lower brain stem. J Neurol Neurosurg Psychiatry (2000) 1.22
Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res (1986) 1.21
Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Cancer Res (1982) 1.20
Expression of mRNAs for neurotrophic factors (NGF, BDNF, NT-3, and GDNF) and their receptors (p75NGFR, trkA, trkB, and trkC) in the adult human peripheral nervous system and nonneural tissues. Neurochem Res (1996) 1.16
Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry (2005) 1.15
An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J Neurol Neurosurg Psychiatry (2000) 1.11
A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity. Biochem Biophys Res Commun (2001) 1.11
Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons. Biochem Biophys Res Commun (1997) 1.09
Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol (1992) 1.08
Specific and potent mitogenic effect of axolemmal fraction on Schwann cells from rat sciatic nerves in serum-containing and defined media. Brain Res (1983) 1.07
Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells (1999) 1.06
Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology (2008) 1.06
Postgastrectomy polyneuropathy with thiamine deficiency. J Neurol Neurosurg Psychiatry (2001) 1.06
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry (2004) 1.05
Morphologic features of the normal human cadaveric spinal cord. Spine (Phila Pa 1976) (1996) 1.04
Size-dependent myelinated fiber loss in the corticospinal tract in Shy-Drager syndrome and amyotrophic lateral sclerosis. Neurology (1987) 1.04
Nonneural nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am J Pathol (1998) 1.02
Spinal and cranial motor nerve roots in amyotrophic lateral sclerosis and X-linked recessive bulbospinal muscular atrophy: morphometric and teased-fiber study. Acta Neuropathol (1981) 1.01
Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjögren's syndrome. J Neurol Neurosurg Psychiatry (2001) 1.00
Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate. Science (1984) 0.99
Founder effect in spinal and bulbar muscular atrophy (SBMA). Hum Mol Genet (1996) 0.98
Axolemma is a mitogen for human Schwann cells. Ann Neurol (1984) 0.98
Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Neuropathol Appl Neurobiol (2007) 0.98
Transforming growth factor-β signaling in motor neuron diseases. Curr Mol Med (2011) 0.97
Cognitive impairment in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry (2007) 0.97
Aggravation of murine experimental allergic encephalomyelitis by administration of T-cell receptor gammadelta-specific antibody. J Neuroimmunol (1997) 0.96
Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet (2001) 0.96
Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 0.96
Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy. Acta Neuropathol (1992) 0.96
Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis. Acta Neuropathol (2000) 0.95
Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res (1997) 0.95
Fast and slow nerve growth factor binding sites in human neuroblastoma and rat pheochromocytoma cell lines: relationship of sites to each other and to neurite formation. J Neurosci (1985) 0.94
Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem Biophys Res Commun (1998) 0.94
Receptor-mediated entry of beta-glucuronidase into the parasitophorous vacuoles of macrophages infected with Leishmania mexicana amazonensis. J Exp Med (1983) 0.94
Pathology of myelinated fibers in cervical and lumbar ventral spinal roots in amyotrophic lateral sclerosis. J Neurol Sci (1981) 0.93
Age-related morphologic changes of the central canal of the human spinal cord. Acta Neuropathol (1999) 0.93
NGF prevention of neurotoxicity induced by cisplatin, vincristine and taxol depends on toxicity of each drug and NGF treatment schedule: in vitro study of adult rat sympathetic ganglion explants. Brain Res (1998) 0.93
Prevalence and incidence rates of chronic inflammatory demyelinating polyneuropathy in the Japanese population. J Neurol Neurosurg Psychiatry (2008) 0.93
Cervical spondylotic amyotrophy. Magnetic resonance imaging demonstration of intrinsic cord pathology. Spine (Phila Pa 1976) (1998) 0.93
Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci (2001) 0.93
Adhesion of axolemmal fragments to Schwann cells: a signal- and target-specific process closely linked to axolemmal induction of Schwann cell mitosis. J Neurosci (1985) 0.92
Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 0.92
[Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS(ALSFRS-R) Japanese version]. No To Shinkei (2001) 0.91
Differential pattern in tissue-specific somatic mosaicism of expanded CAG trinucleotide repeats in dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and X-linked recessive spinal and bulbar muscular atrophy. J Neurol Sci (1996) 0.91
Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. J Neurol Sci (2000) 0.91
Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve (1995) 0.91
Cognitive impairment in spinocerebellar degeneration. Eur Neurol (2009) 0.91
Prefrontal hypoperfusion and cognitive dysfunction correlates in spinocerebellar ataxia type 6. J Neurol Sci (2008) 0.90
Nerve growth factor and serum differentially regulate development of the embryonic otic vesicle and cochleovestibular ganglion in vitro. Dev Biol (1989) 0.90
Segmental anhidrosis in the spinal dermatomes in Sjögren's syndrome-associated neuropathy. Neurology (1993) 0.90
Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjögren's syndrome. J Neurol Neurosurg Psychiatry (2006) 0.90
Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status. Neurology (2001) 0.90
Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res (1999) 0.89
Neurofibromatosis. A review of the clinical problem. Ann N Y Acad Sci (1986) 0.89
Homozygosity for Machado-Joseph disease gene enhances phenotypic severity. J Neurol Neurosurg Psychiatry (1996) 0.89
Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Cancer Res (1986) 0.89
Age-related changes of the myelinated fibers in the human corticospinal tract: a quantitative analysis. Acta Neuropathol (1994) 0.89
Transgenic mice harboring a full-length human mutant DRPLA gene exhibit age-dependent intergenerational and somatic instabilities of CAG repeats comparable with those in DRPLA patients. Hum Mol Genet (1999) 0.89
Differential somatic CAG repeat instability in variable brain cell lineage in dentatorubral pallidoluysian atrophy (DRPLA): a laser-captured microdissection (LCM)-based analysis. Hum Genet (2000) 0.88
Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate. J Neurosci Res (1989) 0.88
Tissue-specific somatic mosaicism in spinal and bulbar muscular atrophy is dependent on CAG-repeat length and androgen receptor--gene expression level. Am J Hum Genet (1999) 0.88
Role for basic fibroblast growth factor (FGF-2) in tyrosine kinase (TrkB) expression in the early development and innervation of the auditory receptor: in vitro and in situ studies. Exp Neurol (2000) 0.88
CAG repeat number correlates with the rate of brainstem and cerebellar atrophy in Machado-Joseph disease. Neurology (1998) 0.88
Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA). Cytogenet Genome Res (2003) 0.88
Appearance of nerve growth factor receptors on cultured neural crest cells. Dev Biol (1985) 0.87
Laminin A, B1, and B2 chain gene expression in transected and regenerating nerves: regulation by axonal signals. J Neurochem (1993) 0.87
Infarction of superior cerebellar artery presenting as cerebellar symptoms. Stroke (1996) 0.87
Autonomic neuropathy associated with autoimmune disease. Neurology (1985) 0.87
The effects of levodopa on apraxia of lid opening: A case report. Neurology (2004) 0.86
Somatic mosaicism of the expanded CAG trinucleotide repeat in mRNAs for the responsible gene of Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA), and spinal and bulbar muscular atrophy (SBMA). Neurochem Res (1998) 0.86